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Abstract
The inhibitory rod cyclic GMP-phosphodiesterase c subunit, PDEc, is a key component of the photoresponse and is required to
support rod integrity. Pdegtm1=Pdegtm1 mice that lack PDEc due to a targeted disruption of the gene encoding PDEc, (Pdeg) suﬀer
from a very rapid and severe photoreceptor degeneration. Previously, deletions in the carboxyl-terminal domain of PDEc blocked
its ability to inhibit trypsin-activated PDE activity, in vitro. In other words, these mutations eliminated PDEc’s control on the
catalytic activity of PDEa and PDEb. To study the in vivo eﬀects resulting from the deletion of the last seven amino acids of the
PDEc carboxyl terminal, this PDEc allele (Del7C) was introduced as a transgene Pdegtm1=Pdegtm1 mice. These animals could only
synthesize transgenic mutant PDEc. The mutant retinas were expected to display a higher basal level of PDE activity and lower
cGMP levels in light and darkness than the PDEc knockout mice, which would allow the rescue of their photoreceptors. Instead,
our results showed that the Del7C transgene could not complement the Pdegtm1=Pdegtm1 mutant for photoreceptor survival. In fact,
animals carrying the Del7C transgene have low PDE activity as well as reduced PDEa and PDEb content.  2002 Elsevier Science
Ltd. All rights reserved.
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Abbreviations: PDE, cGMP phosphodiesterase; Pdeg, gene encoding the c subunit of the cGMP phosphodiesterase; Ta, transducin alpha;
Pdegtm1=Pdegtm1, a mouse line carrying a targeted disruption of Pdeg; TgDel7C, transgenic mice that only express a mutant c subunit of PDE; ERG,
electroretinogram; ROS, rod outer segments
1. Introduction
Neurotransmitters and hormones signal their target
cells through G-protein-coupled receptors. The visual
response to a single photon (Stryer, 1991; Yarﬁtz &
Hurley, 1994) starts with the activation of rhodopsin,
which causes transducin (a heterotrimeric G-protein
fTabcg) (Fung, Hurley, & Stryer, 1981) to exchange its
bound guanosine diphosphate for guanosine triphos-
phate (GTP). Activated transducin molecules, Ta-
GTP, then dissociate from Tbc molecules and bind to
the inhibitory c subunits of cGMP-phosphodiesterase
(PDE, a heterotetrameric enzyme, PDEabc2) (Baehr,
Devlin, & Applebury, 1979; Fung, Young, Yamane,
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& Griswold-Prenner, 1990), thereby relieving the inhi-
bition that the two PDEc subunits exert on the catalytic
PDEa- and b- subunits (Baehr et al., 1979; Deterre,
Bigay, Forquet, Robert, & Charbre, 1988; Fung et al.,
1981; Fung et al., 1990; Wensel & Stryer, 1986). The
resulting activation of PDEab lowers the levels of
cGMP (Miki, Baraban, Keirns, Boyce, & Bitensky,
1975) which leads to closure of cGMP-gated Naþ/Ca2þ
channels on the plasma membrane. This reduces the
entry of Naþ and Ca2þ into the cytoplasm, causing the
entire rod to hyperpolarize.
The regions of PDEc that are required for its various
functions have been studied in the last decade using
reconstituted systems. PDEc contains a central lysine-
rich region, spanning residues Arg24 to Gly45, in which
10 of 13 amino acids are basic. These residues contain
one site for interaction with Ta (Lipkin, Dumler, Mu-
radov, Artemyev, & Etingof, 1988), and are essential for
binding to the PDE catalytic core (Artemyev & Hamm,
1992). The region involved in inhibiting PDE catalytic
activity is thought to lie at the carboxyl terminus, and is
diﬀerent from the region required for binding Ta and
the catalytic PDE subunits (Lipkin et al., 1988). In fact,
deletions and point mutations in the carboxyl termi-
nus were shown not to aﬀect the binding of PDEc to
PDEab, but to decrease inhibition of PDE activity
(Berger, Cerione, & Erickson, 1997; Gonzalez, Cunnick,
& Takemoto, 1991; Takemoto, Hurt, Oppert, & Cun-
nick, 1992). Further, peptides corresponding to the
carboxyl terminus were found to inhibit trypsin-acti-
vated PDE (Granovsky, Natochin, & Artemyev, 1997).
To examine the in vivo function of the inhibitory c
subunits, we generated a mouse line, Pdegtm1=Pdegtm1,
carrying a disruption of the PDEc gene (Tsang et al.,
1996). Based on previous in vitro studies, the loss of the
inhibitory PDEc subunit was expected to generate a
constitutively active PDEab core, as in light activation.
However, the data surprisingly showed that the loss of
the inhibitory PDEc subunit prevented the function-
ing of PDE and elevated rather than depressed cGMP
levels in the developing photoreceptors of homozygous
knockout mice. Examination of mutant retinal extracts
showed that the PDEab catalytic dimer was formed but
lacked hydrolytic activity. These results suggested that
an interaction between the inhibitory PDEc subunit and
the PDE catalytic core may be critical for the proper
action of the enzyme, as well as for the proper folding or
conformation of the catalytic sites of the PDEab core.
The positive participation of PDEc in the formation of
an active PDE complex was unexpected.
To test whether the PDEc domain that maintains the
PDE catalytic core function is in the carboxyl terminus
in vivo, various mutant and wild-type PDEc cDNAs
under the control of the opsin promoter were con-
structed and used to generate transgenic mice by con-
ventional means (Hogan, Beddington, Costantini, &
Lacy, 1994). The transgenes were introduced into ho-
mozygous PDEc knockout mice by breeding, and ani-
mals of the appropriate genotype were identiﬁed by
PCR and Southern blot analysis of genomic DNA. In
this paper, we examine the physiological eﬀects of de-
letion of the last seven amino acids (Del7C) previously
shown to decrease the inhibitory potential of the PDEc
subunit (Gonzalez et al., 1991; Lipkin et al., 1990). This
mutant transgene would be expected to result in the
formation of a constitutively active PDE and thus to
produce low levels of cGMP in the animals carrying it.
The retinas of these mice would also be expected to be in
a state of constant light adaptation and have a saturated
rod response. Contrary to these expectations, we found
that the mutant retinas have a loss of PDE activity and a
decreased PDEa and PDEb content. Furthermore, they
have minimal electroretinogram (ERG) responses.
2. Materials and methods
2.1. Generation of mutant mouse lines
The mice studied in these experiments were used in
accordance to the ARVO statement for the Use of Ani-
mals in Ophthalmic and Vision Research. DNA con-
structs for the expression of PDEc contained 4.4 kb of
the mouse opsin promoter, the complete open reading
frame of the PDEc cDNA (Tuteja & Farber, 1988), and
the polyadenylation signal of the mouse protamine gene
(Lem, Applebury, Falk, Flannery, & Simon, 1991). The
Del7C mutation was introduced by a standard PCR-
based site-speciﬁc mutagenesis strategy (Tsang et al.,
1998). The entire PDEc cDNA coding region in the
transgenic construct was sequenced to conﬁrm the in-
troduction of the deletion and that no other changes had
been created inadvertently. Kpnl and Xbal were used to
excise vector sequences from the constructs. Oocytes
were obtained from superovulated F1(DBA C57BL6)
females mated with homozygous Pdegtm1=Pdegtm1 males.
The construct was injected into the male pronuclei of
oocytes under a depression slide chamber. These micro-
injected oocytes were cultured overnight in M16 and
transferred into the oviducts of 0.5-day p.c. pseudo-
pregnant F1 females. The resulting transgenic mice were
then backcrossed to Pdegtm1=Pdegtm1 mice to place the
transgene into the knockout background. The mice were
also tested for the absence of the rd1 mutation (Pittler &
Baehr, 1991).
2.2. Identiﬁcation of transgenic mice
DNA was isolated from tail tips or liver samples
by homogenizing the tissue, digesting extensively with
proteinase K and extracting with phenol. DNAs were
analyzed by PCR. The DNAs were also digested by Sacl
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and analyzed by Southern blot hybridization with a
PDEc cDNA probe. Additional restriction digests were
performed to analyze the structure of the integrated
sequences, and to insure that the DNA ﬂanking the
transgene was intact.
2.3. Immunoblot analyses
Proteins were separated by polyacrylamide gel
electrophoresis on either a 12% acrylamide/1.5% bis-
acrylamide (for the PDEc subunit) or a 6.5% acryla-
mide/1.5% bis-acrylamide (for PDEa and b subunits)
in a tris/tricine buﬀer system. Proteins were then
transferred to 0.2 lm Immuno-blot PVDF membranes
(BioRad Laboratories, Hercules, CA) by the method of
Towbin, Staehelin, and Gordon (1979), overnight, at 4
V cm1. Membranes were blocked in 3% bovine serum
albumin (BSA) in 500 mM NaCl, 20 mM Tris, pH 7.6,
and 0.1% Tween 20 (BSA-TTBS). For the detection of
PDEc, blots were incubated with a 1:1000 dilution of
a polyclonal peptide antiserum directed against the
N-terminal (amino acid residues 2–16) of the PDEc sub-
unit. The PDEa and b subunits were detected by incu-
bation with a 1:2000 dilution of a polyclonal antiserum
raised against the native enzyme (both antisera were the
generous gift of Dr. Bernard K.K. Fung). Western blots
were visualized with the DuoLux Chemiluminescence
substrate kit (Vector Laboratories, Inc., Burlingame,
CA) utilizing a goat-anti-rabbit IgG-alkaline phospha-
tase conjugate. Blots were exposed to Hyperﬁlm-MP
(Amersham Pharmacia Biotech, Piscataway, NJ) pref-
lashed to increase sensitivity and linearity according to
the SensitizeTM protocol (Amersham Pharmacia Bio-
tech). Signals were analyzed and quantiﬁed on a Power-
Macintosh 9600 computer using the public domain NIH
Image program (developed at the US National Institutes
of Health and available on the Internet at http://rsb.in-
fo.nih.gov/nih-image/).
2.4. Histology
Mice were euthanized with an intraperitoneal in-
jection of ketamine. Each eye was rapidly removed,
punctured at 12:00 along the limbus, and placed in a
separate solution of 3% glutaraldehyde in phosphate
buﬀered saline. After ﬁxation for 1–2 days, the eyes were
washed with saline and the 12:00 limbal puncture was
used to orient the right and left eyes, which were kept in
separate buﬀer, so that the posterior segment containing
the retina could be sectioned along the vertical meridian.
A rectangular piece containing the entire retina from
superior to inferior ora serrata, including the optic nerve
was prepared for postﬁxing in osmic acid, dehydration,
and epon embedding. A corner was cut out at the su-
perior ora to allow identiﬁcation of the upper retinal
half of the segment. Sectioning proceeded along the long
axis of the segment so that each section contained both
upper and lower retina as well as the posterior pole.
These segments were sectioned semi-serially, stained
with toluidine blue, mounted, and examined by light
microscopy.
2.5. Electroretinography
ERGs were obtained from anesthetized animals using
a saline moistened cotton wick electrode that contacted
the cornea. Mice were anesthetized with a mixture of
ketamine (50 mg/kg) and xylazine (10 mg/kg) adminis-
tered either intraperitoneally or intramuscularly. The
pupils were dilated with 1% phenylephrine HCl and 1%
cyclopentolate. Body temperature was maintained at
37 C by a heated stage on which the mouse was laid. A
30 gauge needle was placed subcutaneously on the
forehead as a reference electrode and a ground electrode
subcutaneously on the trunk. The stimuli were light
ﬂashes obtained from a Grass Instruments Inc. strobos-
cope removed from its housing and mounted in a metal
box with a circular aperture, 3 cm in diameter, placed 9
cm from the center of the pupil of the mouse. Neutral
density and/or spectral ﬁlters were placed between this
aperture and the cornea to vary the energy and wave-
length of the ﬂash. Responses were detected with a
Nicolet Instruments CA-1000 oscilloscope, averaging
from 3 to 20 responses to the same ﬂash intensity. Mice
were dark adapted for at least 6 h before testing. Stimu-
lation was begun with 4.8 log units of neutral density
ﬁltering before the strobe ﬂash and responses were av-
eraged to one ﬂash every 3 s. At high ﬂash intensities,
each ﬂash was presented every 15 s. (The duration of a
ﬂash is nominally 10 ls. The frequency response of the
recording system extends from 1 to 500 Hz.)
2.6. PDE activity assay
To measure basal PDE activity, animals were dark-
adapted overnight and retinas dissected under far red
light (Kodak Type 11 ﬁlter), and homogenized in hypo-
tonic buﬀer (10 mM Tris, pH 7.6, 2 mM EDTA, 2 mM
EGTA, 2 lg/ml leupeptin, and 2 lg/ml pepstatin). Ho-
mogenates were centrifuged for 20 min at 12,000 g
and supernatants collected. Aliquots were taken for
protein determination by the method of Peterson (1977)
using BSA as standard, and for cGMP-PDE activity
measurement by the method of Farber and Lolley
(1976), using 250 lM cGMP as substrate. Each reaction
was carried out in triplicate. Three to 10 lg of retinal
protein (depending on the sample) were incubated for
up to 10 min at 37 C with the substrate in 40 mM Tris
buﬀer, pH 7.6, containing 200,000 cpm 3H-cGMP,
5 mM MgCl2, and 1 mM DTT. The reaction was termi-
nated by heating to 80 C for 3 min. 0.4 U of calf in-
testinal alkaline phosphatase was then added to the
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sample and incubation proceeded at 37 C for 10 min.
The resulting 3H-guanosine was separated from other
nucleotides by a resin slurry (AG1-X2, 50–100 mesh,
Biorad Laboratories) and radioactivity was quantiﬁed in
a scintillation counter. Results were expressed as nmol
of cGMP hydrolyzedmin1 mg1 total protein. To mea-
sure trypsin-stimulated PDE activity, trypsin (3u) was
added to a 20 ml sample. After 3 min incubation at
room temperature, the reaction was terminated with 200
mg soybean trypsin inhibitor.
3. Results
3.1. The Del7C mutant transgene temporarily restores the
photoreceptors of the PDEc knockout mice
The Del7C mutation in the C-terminus of PDEc has
been shown to block the inhibition of the catalytic core
PDEab that is mediated by the wild-type PDEc in vitro
(Gonzalez et al., 1991; Lipkin et al., 1990). To test the
eﬀects of this carboxyl-terminal mutation on PDE func-
tion in vivo, transgenic lines (Tg) expressing the Del7C
mutant allele were generated and crossed with Pdegtm1=
Pdegtm1 to obtain mice that only expressed the mutant
PDEc. Two independent TgDel7C lines (1 and 2) were
used for this study. As controls, eight lines of transgenic
mice expressing the wild-type allele in the same back-
ground were also developed (Tsang et al., 1998).
As expected, the wild-type transgene rescued the
Pdegtm1=Pdegtm1 mice photoreceptors. However, the de-
generation of the parental knockout mice was only
slowed down a few days by the mutant Del7C transgene.
Fig. 1 shows light micrographs of retinal sections ob-
tained from Pdegtm1=Pdegtm1 mice with and without the
Del7C transgene at diﬀerent times during postnatal
development. At 14 days of age, retinas from both
Pdegtm1=Pdegtm1 mice with the wild-type control trans-
gene (A) and with the Del7C transgene (B) showed
10–12 rows of photoreceptor nuclei. In contrast, the pa-
rental Pdegtm1=Pdegtm1 mice without the Del7C transgene
showed two to three rows of outer nuclear layer (C). At
17 days of age, the number of photoreceptor nuclei had
decreased to ﬁve rows in Pdegtm1=Pdegtm1 mice with the
Del7C transgene (D) and one to two rows of nuclei in
the parental Pdegtm1=Pdegtm1 mice without the Del7C (E).
By the 21st postnatal day, the Pdegtm1=Pdegtm1 mice with
the Del7C transgene (F) looked like the parental
Pdegtm1=Pdegtm1 mice without the transgene at day 17
(E). These knockout mice had very few photoreceptor
nuclei left at 21 days of age (G). A few days later retinas
from both PDEc knockout mice with or without the
Del7C transgene showed comparable photoreceptor-less
morphology. Thus, the time course of degeneration of
Del7C mice is slower than that of the Pdegtm1=Pdegtm1
mice by approximately a week.
3.2. Physiological features of the mutant mice
To assess the photoresponses at a time when pho-
toreceptors were still present in large numbers, ERG
measurements were made in 12-day-old animals. The
amplitude of the b-waves in the ERG of the two in-
dependent homozygous Pdegtm1=Pdegtm1 lines (=)
with the Del7C transgene (1 and 2) was larger and the
sensitivity higher than those of the Pdegtm1=Pdegtm1
mice (=) at high light intensities (Fig. 2). However,
these responses were much smaller than those of wild-
type mice and decayed gradually with increasing
age, indicating that the abnormality was progressive
(Fig. 3).
3.3. Biochemical analyses of mutant mice
Immunoblots of proteins from retinal homogenates
of 12-day-old postnatal control, Pdegtm1=Pdegtm1 knock-
out, and both lines of TgDel7C mice (Fig. 4A) revealed
the absence of the PDEc subunit in the knockout (lane
2) and TgDel7C animals (lanes 3 and 4). Therefore, we
considered both TgDel7C lines indistinguishable and
equivalent and pooled retinas of these mice in further
experiments. Surprisingly, expression of the catalytic
PDEa and b subunits was reduced by approximately
90% in the TgDel7C animals when compared to both the
þ=þ control and Pdegtm1=Pdegtm1 knockout animals
(Fig. 4B). This reduction in the PDE catalytic core ex-
pression of the TgDel7C animals was reﬂected in the
lower basal PDE activity of the dark-adapted TgDel7C
retinas when compared to that of þ=þ control retinas
(18:3 1:3 and 40:0 9:0 nmol min1 mg1 total pro-
tein, respectively). Furthermore, measurement of total
PDE activity by trypsin activation showed that the reti-
nal TgDel7C PDE activity was only 2.3% of that of the
þ=þ control retina (162 nmolmin1 mg1 total protein
in the TgDel7C compared to 7078 nmolmin1 mg1
total protein in the þ=þ control).
4. Discussion
During light activation, Ta binds to PDEc inducing
a displacement of PDEc’s carboxyl terminus from the
core PDEab catalytic sites and promoting cGMP hy-
drolysis (Skiba, Artemyev, & Hamm, 1995). A confor-
mational change at this carboxyl terminus may in turn
make PDEc’s central region more accessible to Ta
binding (Skiba et al., 1995), leading to acceleration of
Ta-GTPase activity and deactivation of the photores-
ponse.
In vitro experiments have shown that mutations
in the carboxyl terminus of PDEc block its ability to
inhibit trypsin-activated PDE activity (Artemyev, Nato-
chin, Busman, Schey, & Hamm, 1996a; Artemyev,
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Surendran, Lee, & Hamm, 1996b; Berger, Cerione, &
Erickson, 1999; Gonzalez et al., 1991; Stryer, 1991;
Takemoto et al., 1992). The inhibitory domain of PDEc
is located within the last 11 amino acids at the carboxyl
terminus (Skiba et al., 1995). A carboxyl-terminal PDEc
peptide corresponding to amino acid residues 68–87
alone is suﬃcient to completely inhibit trypsin-activated
PDE (Skiba et al., 1995). Brown (1992) also have shown
that carboxyl residues 74–87 are essential for inhibiting
but not for binding to the PDEab catalytic core. Inter-
estingly, recombinant PDEc truncated at amino acid
residue 74 stimulated rather than inhibited trypsin-
activated PDE activity (Brown, 1992). All these obser-
vations indicate that in vitro, the PDEc carboxyl tail is
necessary and suﬃcient to inhibit the PDEab catalytic
activity (Gonzalez et al., 1991; Lipkin et al., 1993; Na-
tochin & Artemyev, 1996; Skiba et al., 1995; Takemoto
et al., 1992). In addition, Del7C was found to decrease
PDEc inhibitory properties without a loss of its aﬃnity
for the catalytic core (Natochin et al., 1991). Based on
these studies, we hypothesized that in the dark the
Del7C retina should display a higher basal level of PDE
activity.
Surprisingly, the PDE activity in retinas of dark-
adapted TgDel7C 12-day-old mice, was higher than that
in retinas of age-matched Pdegtm1=Pdegtm1 animals, but
Fig. 1. Light micrographs of retinas from: (A) an adult Pdegtm1=Pdegtm1 mouse with a wild-type transgene, (B) a 14-day-old Pdegtm1=Pdegtm1 mouse
with the Del7C transgene, (C) a 14-day-old Pdegtm1=Pdegtm1 mouse, (D) and (E) a 17-day-old Pdegtm1=Pdegtm1 mouse with the Del7C transgene and a
Pdegtm1=Pdegtm1 mouse, respectively, (F) and (G) a 21-day-old Pdegtm1=Pdegtm1 mouse with the Del7C transgene and a Pdegtm1=Pdegtm1 knockout
mouse, respectively. RPE: retinal pigment epithelium; OS: outer segments; ONL: outer nuclear layer; INL: inner nuclear layer.
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lower than the PDE activity measured for the 12-day-
old þ=þ control retina which is inhibited by PDEc
(Hurley & Stryer, 1982; Stryer, 1991). The discrepancy
between in vitro and in vivo results can be explained by
the observed reduction in the expression of the catalytic
PDEa and b subunits in the TgDel7C animals (Fig. 4B),
which indirectly suggests a high basal speciﬁc activity of
the TgDel7C PDE.
Furthermore, animals expressing the Del7C mutant
allele did not exhibit a substantial photoresponse as
judged by the ERG measurements (Figs. 2 and 3).
However, the amplitude of the response of TgDel7C
mutants was larger and the response was more sensitive
than that of the Pdegtm1=Pdegtm1 mice. The retinal func-
tion of TgDel7C mutants decayed gradually over time
similar to what happens in individuals with retinitis
pigmentosa. Retinal degeneration in the Del7C may be
due to inability of the truncated PDEc transgene pro-
duct to support suﬃcient expression of the PDE catalytic
core function (Tsang et al., 1996). This suggests that a
novel positive role of PDEc in promoting PDE activity
(Tsang et al., 1996) could be found within its carboxyl
tail. Thus, the PDEc subunit carboxyl terminus is
deemed essential to maintain the proper function and
integrity of the photoreceptors.
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